TY -的T1 -湾2253651治疗阻塞性睡眠呼吸暂停:多中心、双盲、随机对照试验(睡魔)JF -欧洲呼吸杂志乔-和J欧元做10.1183/13993003.01937 -2021 SP - 2101937 AU -托马斯Gaisl AU -克里斯·d·特恩布尔非盟- Gerrit Weimann盟Sigrun昂格尔非盟-鲁道夫手指盟-查尔斯兴盟-彼得·a . Cistulli AU -苏菲西方盟Alan K.I.蒋盟-丹尼·J·埃克特盟Stradling John r . AU -马尔科姆·科勒Y1 - 2021/01/01 UR - //www.qdcxjkg.com/content/early/2021/08/26/13993003.01937 - 2021. -抽象N2 -阻塞性睡眠呼吸暂停(OSA),一些机械处理选项可用,没有药物被批准[1 - 3]。然而,安全、有效的药物治疗与阻塞性睡眠呼吸暂停综合症对许多人有很大的吸引力。FootnotesThis手稿最近发表在《欧洲呼吸杂志》上。这里发表周全之前接受的形式排版,我们的生产团队。这些生产过程完成后,作者已经批准结果证明,本文将最新一期的ERJ在线。请打开或下载PDF查看这篇文章。利益冲突:Gaisl博士报告从拜耳个人费用,在进行这项研究的。利益冲突:特恩布尔报告个人费用来自德国拜耳,博士期间的行为研究。利益冲突:Weimann博士报告成为拜耳制药公司的全职员工。利益冲突:美国昂格尔报告其他从拜耳制药公司在提交工作。利益冲突:手指博士报告和员工的赞助商。利益冲突:兴博士报告和员工的赞助商。利益冲突:PAC预约一个赋予学术椅子上悉尼大学的创建从ResMed资金。 He receives no personal fees and this relationship is managed by an Oversight Committee of the University. He has received research support from ResMed, SomnoMed, Zephyr Sleep Technologies, and Bayer. He is a consultant/adviser to Bayer, Zephyr Sleep Technologies, Signifier Medical Technologies, SomnoMed, and ResMed. He has a pecuniary interest in SomnoMed related to a previous role in R&D (2004).Conflict of interest: Dr. West reports personal fees from Bayer, during the conduct of the study.Conflict of interest: Dr. Chiang reports grants from Bayer, grants from Cooperative Research Centre Project Grant.Conflict of interest: Dr. Eckert reports grants from National Health and Medical Research Council of Australia, grants and personal fees from Bayer, during the conduct of the study; grants and personal fees from Apnimed, outside the submitted work.Conflict of interest: Dr. STRADLING reports grants from Bayer who sponsored this trial through payments to Oxford University Hospitals, personal fees from Bayer, during the conduct of the study; personal fees from Resmed UK, outside the submitted work; .Conflict of interest: Dr. Kohler reports grants and personal fees from Bayer, during the conduct of the study; personal fees from Novartis, grants and personal fees from GSK, grants and personal fees from Roche, personal fees from Boehringer Ingelheim, personal fees from Mundipharma, personal fees from OM Pharma, personal fees from Astra Zeneca, outside the submitted work; and Malcolm Kohler is a founder and board member of Deep Breath Intelligence Ltd, a company that provides services in the field of breath analysis. ER -